Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl2: 1–138, 2012
BianchiNA, StavartLL, AltarelliM, KelevinaT, FaouziM, SchneiderAG: Association of oliguria with acute kidney injury diagnosis, severity assessment, and mortality among patients with critical illness. JAMA Netw Open4: e2133094, 2021PubMed
BianchiNA, StavartLL, AltarelliM, KelevinaT, FaouziM, SchneiderAG: Association of oliguria with acute kidney injury diagnosis, severity assessment, and mortality among patients with critical illness. JAMA Netw Open 4: e2133094, 2021PubMed)| false
PriyankaP, ZarbockA, IzawaJ, GleasonTG, RenfurmRW, KellumJA: The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg162: 143–151.e147, 2021PubMed
PriyankaP, ZarbockA, IzawaJ, GleasonTG, RenfurmRW, KellumJA: The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg 162: 143–151.e147, 2021PubMed)| false
NadimMK, KellumJA, ForniL, FrancozC, AsraniSK, OstermannM, et al.: Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) Joint Multidisciplinary Consensus Meeting. J Hepatol81: 163–183, 2024PubMed
GuthrieG, GuthrieB, WalkerH, JamesMT, SelbyNM, TonelliM, et al.: Developing an AKI consensus definition for database research: Findings from a scoping review and expert opinion using a Delphi process. Am J Kidney Dis79: 488–496 e481, 2022PubMed
GuthrieG, GuthrieB, WalkerH, JamesMT, SelbyNM, TonelliM, : Developing an AKI consensus definition for database research: Findings from a scoping review and expert opinion using a Delphi process. Am J Kidney Dis 79: 488–496 e481, 2022PubMed)| false
JamesMT, LeveyAS, TonelliM, TanZ, BarryR, PannuN, et al.: Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a universal health care system. JAMA Netw Open2: e191795, 2019PubMed
JamesMT, LeveyAS, TonelliM, TanZ, BarryR, PannuN, : Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a universal health care system. JAMA Netw Open 2: e191795, 2019PubMed)| false
MeerschM, WeissR, StraußC, AlbertF, BookeH, ForniL, EPIS-AKI Investigators, et al.: Acute kidney disease beyond day 7 after major surgery: A secondary analysis of the EPIS-AKI trial. Intensive Care Med50: 247–257, 2024PubMed
MeerschM, WeissR, StraußC, AlbertF, BookeH, ForniL, EPIS-AKI Investigators, : Acute kidney disease beyond day 7 after major surgery: A secondary analysis of the EPIS-AKI trial. Intensive Care Med 50: 247–257, 2024PubMed)| false
RenbergM, HertzbergD, Rimes-StigareC, HallqvistL, BellM: Advanced chronic kidney disease after surgery and the contribution of acute kidney disease: A national observational cohort study. Br J Anaesth132: 1238–1247, 2024PubMed
RenbergM, HertzbergD, Rimes-StigareC, HallqvistL, BellM: Advanced chronic kidney disease after surgery and the contribution of acute kidney disease: A national observational cohort study. Br J Anaesth 132: 1238–1247, 2024PubMed)| false
WangH, LambourgE, GuthrieB, MoralesDR, DonnanPT, BellS: Patient outcomes following AKI and AKD: A population-based cohort study. BMC Med20: 229, 2022PubMed
WangH, LambourgE, GuthrieB, MoralesDR, DonnanPT, BellS: Patient outcomes following AKI and AKD: A population-based cohort study. BMC Med 20: 229, 2022PubMed)| false
SiewED, Abdel-KaderK, PerkinsAM, GreevyRA, ParrSK, HornerJ, et al.: Timing of recovery from moderate to severe AKI and the risk for future loss of kidney function. Am J Kidney Dis75: 204–213, 2020PubMed
SiewED, Abdel-KaderK, PerkinsAM, GreevyRA, ParrSK, HornerJ, : Timing of recovery from moderate to severe AKI and the risk for future loss of kidney function. Am J Kidney Dis 75: 204–213, 2020PubMed)| false
HainesRW, FowlerAJ, LiangK, PearseRM, LarssonAO, PuthuchearyZ, et al.: Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness. Clin J Am Soc Nephrol18: 997–1005, 2023PubMed
HainesRW, FowlerAJ, LiangK, PearseRM, LarssonAO, PuthuchearyZ, : Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness. Clin J Am Soc Nephrol 18: 997–1005, 2023PubMed)| false
Nateghi HaredashtF, ViaeneL, VensC, CallewaertN, De CorteW, PottelH: Comparison between cystatin C- and creatinine-based estimated glomerular filtration rate in the follow-up of patients recovering from a stage-3 AKI in ICU. J Clin Med11: 7264, 2022PubMed
Nateghi HaredashtF, ViaeneL, VensC, CallewaertN, De CorteW, PottelH: Comparison between cystatin C- and creatinine-based estimated glomerular filtration rate in the follow-up of patients recovering from a stage-3 AKI in ICU. J Clin Med 11: 7264, 2022PubMed)| false
ChawlaLS, DavisonDL, Brasha-MitchellE, KoynerJL, ArthurJM, ShawAD, et al.: Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care17: R207, 2013PubMed
ChawlaLS, DavisonDL, Brasha-MitchellE, KoynerJL, ArthurJM, ShawAD, : Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 17: R207, 2013PubMed)| false
ChenJJ, ChangCH, HuangYT, KuoG: Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: A systemic review and meta-analysis. Crit Care24: 202, 2020PubMed
ChenJJ, ChangCH, HuangYT, KuoG: Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: A systemic review and meta-analysis. Crit Care 24: 202, 2020PubMed)| false
HosteE, BihoracA, Al-KhafajiA, OrtegaLM, OstermannM, HaaseM, RUBY Investigators, et al.: Identification and validation of biomarkers of persistent acute kidney injury: The RUBY study. Intensive Care Med46: 943–953, 2020PubMed
HosteE, BihoracA, Al-KhafajiA, OrtegaLM, OstermannM, HaaseM, RUBY Investigators, : Identification and validation of biomarkers of persistent acute kidney injury: The RUBY study. Intensive Care Med 46: 943–953, 2020PubMed)| false
MeerschM, WeissR, GerssJ, AlbertF, GruberJ, KellumJA, et al.: Predicting the development of renal replacement therapy indications by combining the furosemide stress test and chemokine (C-C motif) ligand 14 in a cohort of postsurgical patients. Crit Care Med51: 1033–1042, 2023PubMed
MeerschM, WeissR, GerssJ, AlbertF, GruberJ, KellumJA, : Predicting the development of renal replacement therapy indications by combining the furosemide stress test and chemokine (C-C motif) ligand 14 in a cohort of postsurgical patients. Crit Care Med 51: 1033–1042, 2023PubMed)| false
KiernanEA, HuD, PhilbrookHT, IxJH, BonventreJV, CocaSG, et al.: Urinary biomarkers and kidney injury in VA NEPHRON-D: Phenotyping acute kidney injury in clinical trials. Am J Kidney Dis83: 151–161, 2024PubMed
MianoTA, HennessyS, YangW, DunnTG, WeismanAR, OniyideO, et al.: Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: A prospective cohort study. Intensive Care Med48: 1144–1155, 2022PubMed
MianoTA, HennessyS, YangW, DunnTG, WeismanAR, OniyideO, : Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: A prospective cohort study. Intensive Care Med 48: 1144–1155, 2022PubMed)| false
SiewED, MathenyME, IkizlerTA, LewisJB, MillerRA, WaitmanLR, et al.: Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int77: 536–542, 2010PubMed
SiewED, MathenyME, IkizlerTA, LewisJB, MillerRA, WaitmanLR, : Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 77: 536–542, 2010PubMed)| false
RosiS, PianoS, FrigoAC, MorandoF, FasolatoS, CavallinM, et al.: New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: Can we use an imputed value of serum creatinine?Liver Int35: 2108–2114, 2015PubMed
RosiS, PianoS, FrigoAC, MorandoF, FasolatoS, CavallinM, : New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: Can we use an imputed value of serum creatinine? Liver Int 35: 2108–2114, 2015PubMed)| false
JiaHM, HuangLF, ZhengY, LiWX: Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: A meta-analysis. Crit Care21: 77, 2017PubMed
JiaHM, HuangLF, ZhengY, LiWX: Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: A meta-analysis. Crit Care 21: 77, 2017PubMed)| false
WeissR, von GrooteT, OstermannM, LumlertgulN, WeerapolchaiK, GarciaMIM, et al.: The role of cell cycle arrest biomarkers for predicting acute kidney injury in critically ill COVID-19 patients: A multicenter, observational study. Crit Care Med51: 992–1000, 2023PubMed
WeissR, von GrooteT, OstermannM, LumlertgulN, WeerapolchaiK, GarciaMIM, : The role of cell cycle arrest biomarkers for predicting acute kidney injury in critically ill COVID-19 patients: A multicenter, observational study. Crit Care Med 51: 992–1000, 2023PubMed)| false
KüllmarM, MassothC, OstermannM, CamposS, Grau NovellasN, ThomsonG, et al.: Biomarker-guided implementation of the KDIGO guidelines to reduce the occurrence of acute kidney injury in patients after cardiac surgery (PrevAKI-multicentre): Protocol for a multicentre, observational study followed by randomised controlled feasibility trial. BMJ Open10: e034201, 2020PubMed
KüllmarM, MassothC, OstermannM, CamposS, Grau NovellasN, ThomsonG, : Biomarker-guided implementation of the KDIGO guidelines to reduce the occurrence of acute kidney injury in patients after cardiac surgery (PrevAKI-multicentre): Protocol for a multicentre, observational study followed by randomised controlled feasibility trial. BMJ Open 10: e034201, 2020PubMed)| false
MeerschM, SchmidtC, HoffmeierA, Van AkenH, WempeC, GerssJ, et al.: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med43: 1551–1561, 2017PubMed
MeerschM, SchmidtC, HoffmeierA, Van AkenH, WempeC, GerssJ, : Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 43: 1551–1561, 2017PubMed)| false
ZarbockA, KüllmarM, OstermannM, LuccheseG, BaigK, CennamoA, et al.: Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg133: 292–302, 2021PubMed
SeeCY, PanH-C, ChenJ-Y, WuC-Y, LiaoH-W, HuangY-T, et al.: Improvement of composite kidney outcomes by AKI care bundles: A systematic review and meta-analysis. Crit Care27: 390, 2023PubMed
SeeCY, PanH-C, ChenJ-Y, WuC-Y, LiaoH-W, HuangY-T, : Improvement of composite kidney outcomes by AKI care bundles: A systematic review and meta-analysis. Crit Care 27: 390, 2023PubMed)| false
von GrooteT, MeerschM, RomagnoliS, OstermannM, Ripollés-MelchorJ, SchneiderAG, BigpAK-2 Investigators, et al.: Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): Study protocol for an international, prospective, randomised controlled multicentre trial. BMJ Open13: e070240, 2023PubMed
von GrooteT, MeerschM, RomagnoliS, OstermannM, Ripollés-MelchorJ, SchneiderAG, BigpAK-2 Investigators, : Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): Study protocol for an international, prospective, randomised controlled multicentre trial. BMJ Open 13: e070240, 2023PubMed)| false
BouchardJ, AcharyaA, CerdaJ, MaccarielloER, MadarasuRC, TolwaniAJ, et al.: A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol10: 1324–1331, 2015PubMed
BouchardJ, AcharyaA, CerdaJ, MaccarielloER, MadarasuRC, TolwaniAJ, : A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 10: 1324–1331, 2015PubMed)| false
WhiteKC, Serpa-NetoA, HurfordR, ClementP, LauplandKB, SeeE, Queensland Critical Care Research Network (QCCRN), et al.: Sepsis-associated acute kidney injury in the intensive care unit: Incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med49: 1079–1089, 2023PubMed
WhiteKC, Serpa-NetoA, HurfordR, ClementP, LauplandKB, SeeE, Queensland Critical Care Research Network (QCCRN), : Sepsis-associated acute kidney injury in the intensive care unit: Incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med 49: 1079–1089, 2023PubMed)| false
MolinariL, Rio-PertuzGD, PriyankaP, SmithA, MaggioreJC, KennedyJ, ProCESS and ProGReSS-AKI Investigators, et al.: Distribution of acute and chronic kidney disease across clinical phenotypes for sepsis [published online ahead of print Mar 8, 2024]. Chest doi:10.1016/j.chest.2024.03.006PubMed
MolinariL, Rio-PertuzGD, PriyankaP, SmithA, MaggioreJC, KennedyJ, ProCESS and ProGReSS-AKI Investigators, : Distribution of acute and chronic kidney disease across clinical phenotypes for sepsis [published online ahead of print Mar 8, 2024]. Chest doi:10.1016/j.chest.2024.03.006PubMed)| false
RainaR, MahajanZA, VasisthaP, ChakrabortyR, MukundaK, TibrewalA, et al.: Incidence and outcomes of acute kidney injury in COVID-19: A systematic review. Blood Purif51: 199–212, 2022PubMed
DonaldsonLH, VlokR, SakuraiK, BurrowsM, McDonaldG, VenkateshK, et al.: Quantifying the impact of alternative definitions of sepsis-associated acute kidney injury on its incidence and outcomes: A systematic review and meta-analysis [published online ahead of print Apr 1, 2024]. Crit Care Med doi:10.1097/CCM.0000000000006284PubMed
DonaldsonLH, VlokR, SakuraiK, BurrowsM, McDonaldG, VenkateshK, : Quantifying the impact of alternative definitions of sepsis-associated acute kidney injury on its incidence and outcomes: A systematic review and meta-analysis [published online ahead of print Apr 1, 2024]. Crit Care Med doi:10.1097/CCM.0000000000006284PubMed)| false
ZarbockA, WeissR, AlbertF, RutledgeK, KellumJA, BellomoR, EPIS-AKI Investigators, et al.: Epidemiology of surgery associated acute kidney injury (EPIS-AKI): A prospective international observational multi-center clinical study. Intensive Care Med49: 1441–1455, 2023PubMed
NadimMK, ForniLG, BihoracA, HobsonC, KoynerJL, ShawA, et al.: Cardiac and Vascular Surgery–Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc7: e008834, 2018PubMed
BhatrajuPK, ZelnickLR, ChinchilliVM, MoledinaDG, CocaSG, ParikhCR, et al.: Association between early recovery of kidney function after acute kidney injury and long-term clinical outcomes. JAMA Netw Open3: e202682, 2020PubMed
BhatrajuPK, ZelnickLR, ChinchilliVM, MoledinaDG, CocaSG, ParikhCR, : Association between early recovery of kidney function after acute kidney injury and long-term clinical outcomes. JAMA Netw Open 3: e202682, 2020PubMed)| false
HorneKL, Viramontes-HörnerD, PackingtonR, MonaghanJ, ShawS, AkaniA, et al.: A comprehensive description of kidney disease progression after acute kidney injury from a prospective, parallel-group cohort study. Kidney Int104: 1185–1193, 2023PubMed
HorneKL, Viramontes-HörnerD, PackingtonR, MonaghanJ, ShawS, AkaniA, : A comprehensive description of kidney disease progression after acute kidney injury from a prospective, parallel-group cohort study. Kidney Int 104: 1185–1193, 2023PubMed)| false
SeeEJ, JayasingheK, GlassfordN, BaileyM, JohnsonDW, PolkinghorneKR, et al.: Long-term risk of adverse outcomes after acute kidney injury: A systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int95: 160–172, 2019PubMed
SeeEJ, JayasingheK, GlassfordN, BaileyM, JohnsonDW, PolkinghorneKR, : Long-term risk of adverse outcomes after acute kidney injury: A systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int 95: 160–172, 2019PubMed)| false
SiewED, LiuKD, BonnJ, ChinchilliV, DemberLM, GirardTD, et al.: Improving care for patients after hospitalization with AKI. J Am Soc Nephrol31: 2237–2241, 2020PubMed
SiewED, LiuKD, BonnJ, ChinchilliV, DemberLM, GirardTD, : Improving care for patients after hospitalization with AKI. J Am Soc Nephrol 31: 2237–2241, 2020PubMed)| false
BhattM, BenterudE, PalechukT, BignellC, AhmedN, McBrienK, et al.: Advancing community care and access to follow-up after acute kidney injury hospitalization: Design of the AFTER AKI Randomized Controlled Trial. Can J Kidney Health Dis11: 20543581241236419, 2024PubMed
BhattM, BenterudE, PalechukT, BignellC, AhmedN, McBrienK, : Advancing community care and access to follow-up after acute kidney injury hospitalization: Design of the AFTER AKI Randomized Controlled Trial. Can J Kidney Health Dis 11: 20543581241236419, 2024PubMed)| false
OdutayoA, WongCX, FarkouhM, AltmanDG, HopewellS, EmdinCA, et al.: AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol28: 377–387, 2017PubMed
OdutayoA, WongCX, FarkouhM, AltmanDG, HopewellS, EmdinCA, : AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol 28: 377–387, 2017PubMed)| false
De ClercqL, AillietT, SchaubroeckH, HosteEAJ: Acute and chronic cardiovascular consequences of acute kidney injury: A systematic review and meta-analysis. Cardiorenal Med13: 26–33, 2023PubMed
De ClercqL, AillietT, SchaubroeckH, HosteEAJ: Acute and chronic cardiovascular consequences of acute kidney injury: A systematic review and meta-analysis. Cardiorenal Med 13: 26–33, 2023PubMed)| false
AndonovicM, CurleJ, TraynorJP, ShawM, SimMAB, MarkPB, et al.: Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors. BJA Open8: 100243, 2023PubMed
AndonovicM, CurleJ, TraynorJP, ShawM, SimMAB, MarkPB, : Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors. BJA Open 8: 100243, 2023PubMed)| false
NguyenDN, HuyghensL, ParraJ, SchiettecatteJ, SmitzJ, VincentJL: Hypotension and a positive fluid balance are associated with delirium in patients with shock. PloS One13: e0200495, 2018PubMed
NguyenDN, HuyghensL, ParraJ, SchiettecatteJ, SmitzJ, VincentJL: Hypotension and a positive fluid balance are associated with delirium in patients with shock. PloS One 13: e0200495, 2018PubMed)| false
LiuM, LiangY, ChigurupatiS, LathiaJD, PletnikovM, SunZ, et al.: Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol19: 1360–1370, 2008PubMed
JäckelM, AicherN, RilingerJ, BemtgenX, WidmeierE, WengenmayerT, et al.: Incidence and predictors of delirium on the intensive care unit in patients with acute kidney injury, insight from a retrospective registry. Sci Rep11: 17260, 2021PubMed
JäckelM, AicherN, RilingerJ, BemtgenX, WidmeierE, WengenmayerT, : Incidence and predictors of delirium on the intensive care unit in patients with acute kidney injury, insight from a retrospective registry. Sci Rep 11: 17260, 2021PubMed)| false
MagadiW, PerachaJ, McKaneWS, SavinoM, BraddonF, SteenkampR, et al.: Do outcomes for patients with hospital-acquired acute kidney injury (H-AKI) vary across specialties in England?BMC Nephrol24: 193, 2023PubMed